Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, 2x2 Factorial Trial to Assess the Efficacy of Antiviral Therapy in Women and Infants in Reducing Vertical Transmission of Hepatitis B in Africa

NCT04704024 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT04704024
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04704024 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, 2x2 Factorial Trial to Assess the Efficacy of Antiviral Therapy in Women and Infants in Reducing Vertical Transmission of Hepatitis B in Africa
Lead sponsor
University of Alabama at Birmingham
Phase
Phase 3
Overall status
Active, not recruiting
Start date
September 3, 2021
Completion date
December 31, 2026
Enrollment
334 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b infection